JP2016534022A5 - - Google Patents

Download PDF

Info

Publication number
JP2016534022A5
JP2016534022A5 JP2016503264A JP2016503264A JP2016534022A5 JP 2016534022 A5 JP2016534022 A5 JP 2016534022A5 JP 2016503264 A JP2016503264 A JP 2016503264A JP 2016503264 A JP2016503264 A JP 2016503264A JP 2016534022 A5 JP2016534022 A5 JP 2016534022A5
Authority
JP
Japan
Prior art keywords
seq
sequence
variable region
set forth
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016503264A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016534022A (ja
JP6431523B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2014/070661 external-priority patent/WO2015016386A1/en
Publication of JP2016534022A publication Critical patent/JP2016534022A/ja
Publication of JP2016534022A5 publication Critical patent/JP2016534022A5/ja
Application granted granted Critical
Publication of JP6431523B2 publication Critical patent/JP6431523B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016503264A 2013-07-30 2014-07-30 抗ホスホリパーゼd4抗体を含む医薬 Active JP6431523B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013158258 2013-07-30
JP2013158258 2013-07-30
PCT/JP2014/070661 WO2015016386A1 (en) 2013-07-30 2014-07-30 Medicament comprising anti-phospholipase d4 antibody

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018206702A Division JP2019014759A (ja) 2013-07-30 2018-11-01 抗ホスホリパーゼd4抗体を含む医薬

Publications (3)

Publication Number Publication Date
JP2016534022A JP2016534022A (ja) 2016-11-04
JP2016534022A5 true JP2016534022A5 (enExample) 2017-09-07
JP6431523B2 JP6431523B2 (ja) 2018-11-28

Family

ID=51493000

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016503264A Active JP6431523B2 (ja) 2013-07-30 2014-07-30 抗ホスホリパーゼd4抗体を含む医薬
JP2018206702A Ceased JP2019014759A (ja) 2013-07-30 2018-11-01 抗ホスホリパーゼd4抗体を含む医薬
JP2019173621A Active JP6843449B2 (ja) 2013-07-30 2019-09-25 抗ホスホリパーゼd4抗体を含む医薬

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018206702A Ceased JP2019014759A (ja) 2013-07-30 2018-11-01 抗ホスホリパーゼd4抗体を含む医薬
JP2019173621A Active JP6843449B2 (ja) 2013-07-30 2019-09-25 抗ホスホリパーゼd4抗体を含む医薬

Country Status (17)

Country Link
US (2) US20160168266A1 (enExample)
EP (1) EP3027656B1 (enExample)
JP (3) JP6431523B2 (enExample)
KR (1) KR102367760B1 (enExample)
CN (1) CN105745226B (enExample)
AU (1) AU2014297217B2 (enExample)
BR (1) BR112016002001B1 (enExample)
CA (1) CA2919736C (enExample)
DK (1) DK3027656T3 (enExample)
ES (1) ES2736324T3 (enExample)
HU (1) HUE044469T2 (enExample)
MX (1) MX381725B (enExample)
PL (1) PL3027656T3 (enExample)
RU (1) RU2709741C2 (enExample)
SG (2) SG10201800592SA (enExample)
TR (1) TR201910330T4 (enExample)
WO (1) WO2015016386A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20210044A1 (ar) 2010-12-30 2017-06-16 Takeda Pharmaceuticals Co الأجسام المضادة لـ cd38
DK2809683T3 (en) * 2012-01-31 2018-12-10 Sbi Biotech Co Ltd ANTI-phospholipase D 4 ANTIBODY
SG10201800592SA (en) * 2013-07-30 2018-03-28 Sbi Biotech Co Ltd Medicament comprising anti-phospholipase d4 antibody
BR112019000544A2 (pt) 2016-07-15 2019-04-24 Takeda Pharmaceutical Company Limited métodos e materiais para avaliar resposta a terapias de plasmoblasto- e depleção celular plasmática
AU2019208102B2 (en) 2018-01-12 2025-10-09 Takeda Pharmaceutical Company Limited Subcutaneous dosing of anti-CD38 antibodies
JP7140367B2 (ja) * 2018-05-31 2022-09-21 国立大学法人 東京大学 ヒト由来サンプルにおける可溶型tlr7の分析

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2091684T3 (es) * 1992-11-13 1996-11-01 Idec Pharma Corp Aplicacion terapeutica de anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de las celulas b.
WO2000011015A1 (en) * 1998-08-24 2000-03-02 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
EP1392855A4 (en) * 2000-12-07 2005-05-25 Millennium Pharm Inc METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF VIRAL DISEASES VIA GENE 55092
JP2013052781A (ja) 2011-09-05 2013-03-21 Tokai Rika Co Ltd 車両用ミラー装置
DK2809683T3 (en) * 2012-01-31 2018-12-10 Sbi Biotech Co Ltd ANTI-phospholipase D 4 ANTIBODY
SG10201800592SA (en) * 2013-07-30 2018-03-28 Sbi Biotech Co Ltd Medicament comprising anti-phospholipase d4 antibody

Similar Documents

Publication Publication Date Title
JP2016534022A5 (enExample)
JP2013060443A5 (enExample)
JP2016029056A5 (enExample)
JP2012012402A5 (enExample)
JP2013198490A5 (enExample)
JP2014111644A5 (enExample)
JP2014524733A5 (enExample)
JP2015535828A5 (enExample)
JP2014205674A5 (enExample)
JP2009519718A5 (enExample)
JP2013538057A5 (enExample)
JP2017505125A5 (enExample)
RU2016100892A (ru) Антитела против tweakr и их применение
RU2008129111A (ru) Антитела к ox40l и способы их применения
JP2013506675A5 (enExample)
JP2012143232A5 (enExample)
RU2010107175A (ru) Антитела человека к cd20 человека и способ их использования
JP2017513813A5 (enExample)
JP2014511179A5 (enExample)
RU2015136078A (ru) Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний
JP2007527406A5 (enExample)
RU2013140350A (ru) Антитела против человеческого il33r и их применение
EP4240758A1 (en) Neutralizing anti-sars-cov-2 antibodies
JP2012501669A5 (enExample)
JP2016516400A5 (enExample)